HOME › DRUGS › RAMUCIRUMAB
ACTIVE SUBSTANCE / INN

RAMUCIRUMAB

Brand name(s): CYRAMZA, Cyramza
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125477
Stomach Neoplasms
ACTIVE SUBSTANCE
Ramucirumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Eli Lilly Nederland B.V., ELI LILLY AND CO
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CYRAMZABLA125477ELI LILLY AND COPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CyramzaEli Lilly Nederland B.V.Authorised19/12/2014Stomach Neoplasms

FULL INTELLIGENCE ON RAMUCIRUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →